NIV and CPAP Failure Predictors in COVID-19 Associated Respiratory Failure
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- HACOR score efficacy
研究概览
简要总结
Evaluate HACOR socre utility and efficacy in predicting NIV and/or CPAP failure in patients with COVID-19 associated respiratory failure.
Propose adaptations to HACOR score based on the "state of art" of COVID-19
详细描述
Evaluate HACOR socre utility and efficacy in predicting NIV and/or CPAP failure in patients with COVID-19 associated respiratory failure.
Propose adaptations to HACOR score based on the "state of art" of COVID-19
- this adaptations may include radiologic aggravation and monitoring of CRF, ferritin, LDH, d-dimers, NT-proBNP, troponin I, GOT, GPT, blood count
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with acute respiratory failure due to COVID-19 who have initiated NIV or CPAP based on assistant clinician decision
排除标准
- •Patients with imediate indication to invasive mechanical ventilation
- •Patients with any formal contraindication to noninvasive respiratory support
结局指标
主要结局
HACOR score efficacy
时间窗: 1 hour after initation of CPAP or NIV
Analyze if HACOR score is effective in predicting nonivasive ventilation failure in COVID-19 associated respiratory failure
HACOR score addaptation
时间窗: 1 - 2 weeks
Analyze the role of possible variables to be added to HACOR score in order to improve efficay in COVID-19 patients
次要结局
未报告次要终点
研究者
Miguel Filipe Martins de Matos Navarro Guia
Dr.
Hospital General Universitario Morales Meseguer